CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C18204 | BRD-K49490091 | BRD-K49490091 | -- | -- | -- | Details |
| C18205 | BRD-K49504902 | SEP-227900 | DAO | D-Amino Acid Oxidase Inhibitor | -- | Details |
| C18206 | BRD-K49507197 | BRD-K49507197 | -- | -- | -- | Details |
| C18207 | BRD-K49508167 | BRD-K49508167 | -- | -- | -- | Details |
| C18208 | BRD-K49510739 | BRD-K49510739 | -- | -- | -- | Details |
| C18209 | BRD-K49512493 | BRD-K49512493 | -- | -- | -- | Details |
| C18210 | BRD-K49519092 | immethridine | HRH3 | Histamine receptor agonist | -- | Details |
| C18211 | BRD-K49519144 | LY-2140023 | GRM3 | Glutamate receptor agonist | -- | Details |
| C18212 | BRD-K49522529 | alfacalcidol | VDR | Vitamin D receptor agonist | -- | Details |
| C18213 | BRD-K49525275 | BRD-K49525275 | -- | -- | -- | Details |
| C18214 | BRD-K49525301 | BRD-K49525301 | -- | -- | -- | Details |
| C18215 | BRD-K49526793 | BRD-K49526793 | -- | -- | -- | Details |
| C18216 | BRD-K49527160 | Z-221560030 | -- | -- | -- | Details |
| C18217 | BRD-K49528360 | BRD-K49528360 | -- | -- | -- | Details |
| C18218 | BRD-K49529874 | BRD-K49529874 | -- | -- | -- | Details |
| C18219 | BRD-K49530286 | BRD-K49530286 | -- | -- | -- | Details |
| C18220 | BRD-K49534870 | BRD-K49534870 | -- | -- | -- | Details |
| C18221 | BRD-K49545421 | BRD-K49545421 | -- | -- | -- | Details |
| C18222 | BRD-K49552510 | BRD-K49552510 | -- | -- | -- | Details |
| C18223 | BRD-K49553303 | BRD-K49553303 | -- | -- | -- | Details |
| C18224 | BRD-K49555808 | BMS-707035 | -- | -- | -- | Details |
| C18225 | BRD-K49562544 | BRD-K49562544 | -- | -- | -- | Details |
| C18226 | BRD-K49567165 | BRD-K49567165 | -- | -- | -- | Details |
| C18227 | BRD-K49570068 | BRD-K49570068 | -- | -- | -- | Details |
| C18228 | BRD-K49573242 | BRD-K49573242 | -- | -- | -- | Details |
| C18229 | BRD-K49577446 | flunisolide | NR3C1 | Cytochrome P450 inhibitor | -- | Details |
| C18230 | BRD-K49577636 | BRD-K49577636 | -- | -- | -- | Details |
| C18231 | BRD-K49579550 | BRD-K49579550 | -- | -- | -- | Details |
| C18232 | BRD-K49584388 | BRD-K49584388 | -- | -- | -- | Details |
| C18233 | BRD-K49584663 | BRD-K49584663 | -- | -- | -- | Details |
| C18234 | BRD-K49587132 | SA-427604 | -- | -- | -- | Details |
| C18235 | BRD-K49594309 | BRD-K49594309 | -- | -- | -- | Details |
| C18236 | BRD-K49595590 | BRD-K49595590 | -- | -- | -- | Details |
| C18237 | BRD-K49596872 | BRD-K49596872 | -- | -- | -- | Details |
| C18238 | BRD-K49597140 | BRD-K49597140 | -- | -- | -- | Details |
| C18239 | BRD-K49612115 | BRD-K49612115 | -- | -- | -- | Details |
| C18240 | BRD-K49620695 | BRD-K49620695 | -- | -- | -- | Details |
| C18241 | BRD-K49623506 | BRD-K49623506 | -- | -- | -- | Details |
| C18242 | BRD-K49628278 | BRD-K49628278 | -- | -- | -- | Details |
| C18243 | BRD-K49630153 | BRD-K49630153 | -- | -- | -- | Details |
| C18244 | BRD-K49630774 | BRD-K49630774 | -- | -- | -- | Details |
| C18245 | BRD-K49634971 | BRD-K49634971 | -- | -- | -- | Details |
| C18246 | BRD-K49635910 | BRD-K49635910 | -- | -- | -- | Details |
| C18247 | BRD-K49639333 | BRD-K49639333 | -- | -- | -- | Details |
| C18248 | BRD-K49640920 | BRD-K49640920 | -- | -- | -- | Details |
| C18249 | BRD-K49656278 | BRD-K49656278 | -- | -- | -- | Details |
| C18250 | BRD-K49657628 | BRD-K49657628 | -- | -- | tyrphostin-AG-18 | Details |
| C18251 | BRD-K49659981 | BRD-K49659981 | -- | -- | -- | Details |
| C18252 | BRD-K49662642 | BRD-K49662642 | -- | -- | -- | Details |
| C18253 | BRD-K49664555 | BRD-K49664555 | -- | -- | -- | Details |
| C18254 | BRD-K49666076 | BRD-K49666076 | -- | -- | -- | Details |
| C18255 | BRD-K49668410 | BRD-K49668410 | -- | -- | clarithromycin | Details |
| C18256 | BRD-K49669041 | BX-912 | PDK1; PDPK1 | Pyruvate dehydrogenase kinase inhibitor | -- | Details |
| C18257 | BRD-K49669424 | bretylium | -- | -- | -- | Details |
| C18258 | BRD-K49669601 | BRD-K49669601 | -- | -- | -- | Details |
| C18259 | BRD-K49671696 | ketanserin | HTR2A; HTR2C | Serotonin receptor antagonist | -- | Details |
| C18260 | BRD-K49673270 | BRD-K49673270 | -- | -- | -- | Details |
| C18261 | BRD-K49675259 | BRD-K49675259 | -- | -- | -- | Details |
| C18262 | BRD-K49676673 | BRD-K49676673 | -- | -- | -- | Details |
| C18263 | BRD-K49681465 | BRD-K49681465 | -- | -- | -- | Details |
| C18264 | BRD-K49685476 | TTNPB | RARB | Retinoid receptor agonist | -- | Details |
| C18265 | BRD-K49685495 | BRD-K49685495 | -- | -- | -- | Details |
| C18266 | BRD-K49687221 | BRD-K49687221 | -- | -- | -- | Details |
| C18267 | BRD-K49687815 | BRD-K49687815 | -- | -- | -- | Details |
| C18268 | BRD-K49689003 | BRD-K49689003 | -- | -- | -- | Details |
| C18269 | BRD-K49698948 | BRD-K49698948 | -- | -- | -- | Details |
| C18270 | BRD-K49702326 | BRD-K49702326 | -- | -- | -- | Details |
| C18271 | BRD-K49704392 | BRD-K49704392 | -- | -- | -- | Details |
| C18272 | BRD-K49705175 | BRD-K49705175 | -- | -- | -- | Details |
| C18273 | BRD-K49707067 | BRD-K49707067 | -- | -- | -- | Details |
| C18274 | BRD-K49712247 | BRD-K49712247 | -- | -- | -- | Details |
| C18275 | BRD-K49721311 | BRD-K49721311 | -- | -- | -- | Details |
| C18276 | BRD-K49723079 | BRD-K49723079 | -- | -- | -- | Details |
| C18277 | BRD-K49723782 | BRD-K49723782 | -- | -- | -- | Details |
| C18278 | BRD-K49733350 | BRD-K49733350 | -- | -- | -- | Details |
| C18279 | BRD-K49733809 | BRD-K49733809 | -- | -- | -- | Details |
| C18280 | BRD-K49736551 | BRD-K49736551 | -- | -- | -- | Details |
| C18281 | BRD-K49738502 | BRD-K49738502 | -- | -- | -- | Details |
| C18282 | BRD-K49739160 | BRD-K49739160 | -- | -- | -- | Details |
| C18283 | BRD-K49742819 | BRD-K49742819 | -- | -- | -- | Details |
| C18284 | BRD-K49745710 | BRD-K49745710 | -- | -- | -- | Details |
| C18285 | BRD-K49745983 | BRD-K49745983 | -- | -- | -- | Details |
| C18286 | BRD-K49749421 | BRD-K49749421 | -- | -- | -- | Details |
| C18287 | BRD-K49751344 | BRD-K49751344 | -- | -- | -- | Details |
| C18288 | BRD-K49755501 | BRD-K49755501 | -- | -- | -- | Details |
| C18289 | BRD-K49759007 | BRD-K49759007 | -- | -- | 4-hydroxy-phenazone | Details |
| C18290 | BRD-K49776472 | SKF-91488 | HNMT | Histamine N-methyltransferase inhibitor | -- | Details |
| C18291 | BRD-K49781215 | BRD-K49781215 | -- | -- | -- | Details |
| C18292 | BRD-K49783248 | decamethonium | CHRNA2 | Acetylcholine receptor agonist | -- | Details |
| C18293 | BRD-K49791723 | BRD-K49791723 | -- | -- | -- | Details |
| C18294 | BRD-K49797414 | BRD-K49797414 | -- | -- | -- | Details |
| C18295 | BRD-K49807096 | benazepril | ACE | Angiotensin converting enzyme inhibitor | -- | Details |
| C18296 | BRD-K49807497 | BRD-K49807497 | -- | -- | -- | Details |
| C18297 | BRD-K49808142 | tyramine | -- | -- | -- | Details |
| C18298 | BRD-K49810818 | sorafenib | FGFR1; FLT1; FLT3; FLT4; KDR; KIT; DDR2; PDGFRB; RAF1; RET; BRAF | KIT inhibitor; RAF inhibitor; FLT3 inhibitor; PDGFR inhibitor; VEGFR inhibitor; RET tyrosine kinase inhibitor | -- | Details |
| C18299 | BRD-K49810938 | BRD-K49810938 | -- | -- | -- | Details |
| C18300 | BRD-K49814456 | BRD-K49814456 | -- | -- | -- | Details |
| C18301 | BRD-K49830011 | BRD-K49830011 | -- | -- | -- | Details |
| C18302 | BRD-K49831518 | BRD-K49831518 | -- | -- | -- | Details |
| C18303 | BRD-K49840922 | etofylline-clofibrate | PPARA | Platelet aggregation inhibitor; Lipase clearing factor inhibitor | -- | Details |